CD274 and esophageal squamous cell carcinoma: Pointing in the same direction, our data, generated with a robust and highly specific PD-L1 (SP263) antibody [33] [34–36] in a comparatively large and extensively investigated, therapy naive tumor series, associate PD-L1high ESCC with favorable OS, DSS and DFS survival in uni- and multivariate analyses.